Sai Parenteral's Ltd.

540.85-0.47%

2026-08-21

saiparenterals.comBSE: 544742NSE: SAIPARENT
Market Cap₹ 2,387 Cr.
Current Price₹ 543
High / Low₹ 706 / 400
Stock P/E167.4
Book Value₹ 177
Price to Book3.08
Dividend Yield0.00 %
ROCE16.7 %
ROE17.2 %
Face Value₹ 5

Add ratio to table

ABOUT

KEY POINTS

PROS

    CONS

    • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.35x)
    • Operating cash flow has been negative in recent years
    • Inventory has been piling up - inventory days up from 60 to 99
    • Though reporting repeated profits, the company pays out little dividend (0.0%)
    • Debtor days have increased from 223 to 284

    * The pros and cons are machine generated based on quantitative rules.

    Peer comparison

    EDIT COLUMNS
    S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
    1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
    2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
    3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
    4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
    5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
    6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
    7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
    8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
    9.LAURUSLABS1807.0089.3097634.420.11362.07123.942026.3129.1018.2031.50
    10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
    11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
    12.SAIPARENT540.25167.392386.780.0079.231786.727.0313.16
    Detailed Comparison with:

    Quarterly Results

    Consolidated Figures in Rs. Crores / View Standalone

    Jun 2025
    33
    33
    Operating Profit
    OPM %
    Other Income
    1
    Interest
    2
    Depreciation
    1
    2
    Tax %
    29.43%
    Net Profit
    1
    0
    Equity Capital
    13
    Reserves
    0
    Promoter Pledge %
    0.00%
    Equity Capital
    13
    Reserves
    0
    Promoter Pledge %
    0.00%
    Mar 2026
    198
    172
    Operating Profit
    OPM %
    Other Income
    3
    Interest
    8
    Depreciation
    8
    12
    Tax %
    -6.13%
    Net Profit
    13
    4
    Equity Capital
    22
    Reserves
    0
    Promoter Pledge %
    0.00%
    Equity Capital
    22
    Reserves
    0
    Promoter Pledge %
    0.00%
    Jun 2026
    179
    173
    Operating Profit
    OPM %
    Other Income
    4
    Interest
    9
    Depreciation
    8
    10
    Tax %
    19.07%
    Net Profit
    8
    0
    Equity Capital
    22
    Reserves
    0
    Promoter Pledge %
    0.00%
    Equity Capital
    22
    Reserves
    0
    Promoter Pledge %
    0.00%

    Profit & Loss

    Consolidated Figures in Rs. Crores / View Standalone

    Mar 2023
    97
    78
    Operating Profit
    19
    OPM %
    19
    Other Income
    0
    Interest
    6
    Depreciation
    6
    7
    Tax %
    40
    Net Profit
    4
    EPS
    6
    Dividend Payout %
    0
    Minority Interest
    0
    Share of Associates
    0
    Adjusted EPS
    3
    Minority Interest
    0
    Share of Associates
    0
    Adjusted EPS
    3
    Mar 2024
    154
    122
    Operating Profit
    33
    OPM %
    22
    Other Income
    2
    Interest
    11
    Depreciation
    9
    13
    Tax %
    33
    Net Profit
    8
    EPS
    7
    Dividend Payout %
    0
    Minority Interest
    0
    Share of Associates
    0
    Adjusted EPS
    3
    Minority Interest
    0
    Share of Associates
    0
    Adjusted EPS
    3
    Mar 2025
    163
    124
    Operating Profit
    40
    OPM %
    25
    Other Income
    1
    Interest
    12
    Depreciation
    8
    20
    Tax %
    28
    Net Profit
    14
    EPS
    5
    Dividend Payout %
    0
    Minority Interest
    -0
    Share of Associates
    0
    Adjusted EPS
    5
    Minority Interest
    -0
    Share of Associates
    0
    Adjusted EPS
    5

    COMPOUNDED SALES GROWTH

    10 Years:
    5 Years:
    3 Years:

    COMPOUNDED PROFIT GROWTH

    10 Years:
    5 Years:
    3 Years:

    STOCK PRICE CAGR

    10 Years:
    5 Years:
    3 Years:
    1 Year:

    RETURN ON EQUITY

    10 Years:
    5 Years:
    3 Years:
    16%
    Last Year:
    17%

    Balance Sheet

    Consolidated Figures in Rs. Crores / View Standalone

    Corporate actions

    No bonus data found

    Mar 2023
    Equity Capital
    7
    24
    43
    Trade Payables
    22
    37
    Total Liabilities
    134
    44
    Capital Work in Progress
    2
    13
    0
    Cash & Bank
    0
    75
    Total Assets
    134
    Total Debt
    69
    Net Working Capital
    5
    Contingent Liabilities
    2
    Book Value per Share
    44.03
    Face Value
    10.00
    Total Debt
    69
    Net Working Capital
    5
    Contingent Liabilities
    2
    Book Value per Share
    44.03
    Face Value
    10.00
    Mar 2024
    Equity Capital
    13
    61
    71
    Trade Payables
    53
    69
    Total Liabilities
    267
    70
    Capital Work in Progress
    0
    37
    127
    Cash & Bank
    4
    29
    Total Assets
    267
    Total Debt
    119
    Net Working Capital
    35
    Contingent Liabilities
    4
    Book Value per Share
    56.27
    Face Value
    10.00
    Total Debt
    119
    Net Working Capital
    35
    Contingent Liabilities
    4
    Book Value per Share
    56.27
    Face Value
    10.00
    Mar 2025
    Equity Capital
    13
    80
    73
    Trade Payables
    58
    47
    Total Liabilities
    272
    53
    Capital Work in Progress
    0
    51
    127
    Cash & Bank
    2
    38
    Total Assets
    272
    Total Debt
    94
    Net Working Capital
    38
    Contingent Liabilities
    2
    Book Value per Share
    35.19
    Face Value
    5.00
    Total Debt
    94
    Net Working Capital
    38
    Contingent Liabilities
    2
    Book Value per Share
    35.19
    Face Value
    5.00

    Cash Flows

    Consolidated Figures in Rs. Crores / View Standalone

    Mar 2023
    -13
    Cash from Investing
    -19
    Cash from Financing
    24
    -8
    Free Cash Flow
    -13
    OCF / Net Profit
    -2.92
    Cumulative 5-Year FCF
    0
    OCF / Net Profit
    -2.92
    Cumulative 5-Year FCF
    0
    Mar 2024
    -30
    Cash from Investing
    -46
    Cash from Financing
    79
    2
    Free Cash Flow
    -72
    OCF / Net Profit
    -3.54
    Cumulative 5-Year FCF
    0
    OCF / Net Profit
    -3.54
    Cumulative 5-Year FCF
    0
    Mar 2025
    33
    Cash from Investing
    0
    Cash from Financing
    -36
    -2
    Free Cash Flow
    33
    OCF / Net Profit
    2.30
    Cumulative 5-Year FCF
    0
    OCF / Net Profit
    2.30
    Cumulative 5-Year FCF
    0

    Ratios

    Consolidated Figures in Rs. Crores / View Standalone

    Mar 2023
    EPS (₹)
    6.12
    Book Value (₹)
    44.03
    Dividend per Share (₹)
    0.00
    Cash EPS (₹)
    7.11
    Operating Margin %
    19.39%
    Net Margin %
    4.52%
    ROE %
    13.90%
    ROCE %
    12.97%
    3.27%
    Debtor Days
    231
    Inventory Days
    50
    Payable Days
    140
    140
    Debt to Equity (x)
    2.18x
    Interest Coverage (x)
    2.27x
    1.07x
    Revenue Growth %
    0.00%
    Operating Profit Growth %
    0.00%
    Net Profit Growth %
    0.00%
    0.00%
    P/E (x)
    0.00x
    P/B (x)
    0.00x
    Dividend Yield %
    0.00%
    0.00x
    Mar 2024
    EPS (₹)
    6.71
    Book Value (₹)
    56.27
    Dividend per Share (₹)
    0.00
    Cash EPS (₹)
    6.73
    Operating Margin %
    20.54%
    Net Margin %
    5.47%
    ROE %
    15.87%
    ROCE %
    16.14%
    4.19%
    Debtor Days
    223
    Inventory Days
    60
    Payable Days
    144
    139
    Debt to Equity (x)
    1.59x
    Interest Coverage (x)
    2.13x
    1.23x
    Revenue Growth %
    58.85%
    Operating Profit Growth %
    76.34%
    Net Profit Growth %
    92.30%
    9.60%
    P/E (x)
    0.00x
    P/B (x)
    0.00x
    Dividend Yield %
    0.00%
    3.86x
    Mar 2025
    EPS (₹)
    5.33
    Book Value (₹)
    35.19
    Dividend per Share (₹)
    0.00
    Cash EPS (₹)
    8.50
    Operating Margin %
    24.15%
    Net Margin %
    8.85%
    ROE %
    17.15%
    ROCE %
    16.70%
    5.35%
    Debtor Days
    284
    Inventory Days
    99
    Payable Days
    215
    167
    Debt to Equity (x)
    1.00x
    Interest Coverage (x)
    2.67x
    1.23x
    Revenue Growth %
    6.08%
    Operating Profit Growth %
    20.93%
    Net Profit Growth %
    71.44%
    -20.46%
    P/E (x)
    0.00x
    P/B (x)
    0.00x
    Dividend Yield %
    0.00%
    2.63x

    Shareholding Pattern

    Numbers in percentages

    TRADES
    Mar 2026
    51.16
    5.73
    12.86
    Government
    0.00
    30.26
    Jun 2026
    51.16
    4.03
    8.52
    Government
    0.00
    36.29

    Documents

    Announcements

    • Copy of Newspaper Publication

      2026-08-20 - Intimation-Newspaper Publication of Notice of 25" Annual General Meeting of the Company for the financial year 2025-26.

    • Copy of Newspaper Publication

      2026-08-20 - Submission of Newspaper Publication(s) in PAS-1 for change and variation in the objects of utilization of the Initial Public Offering ( IPO ) proceeds

    Annual Reports

    Nothing filed yet.

    Credit Ratings

    Nothing filed yet.

    Concalls